| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |